Acute Liver Failure

Zakim and Boyer's Hepatology

Volumn , Issue , 2012, Pages 327-351

  Stravitz, R Todd ^a   Kramer, David J ^b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Medical School Biological Resource Unit   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528540     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0881-3.00020-6     Document Type: Chapter

References (288)

1. Lucke B, Mallory T The fulminant form of epidemic hepatitis. Am J Pathol 1946, 22:867-947.
2. Gimson AE, et al. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986, 6(2):288-294.
3. O'Grady JG, Schalm SW, Williams R Acute liver failure: redefining the syndromes. Lancet 1993, 342(8866):273-275.
4. O'Grady JG, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97(2):439-445.
5. Ellis AJ, et al. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 1995, 23(4):363-372.
6. Lee WM Acute liver failure in the United States. Semin Liver Dis 2003, 23(3):217-226.
7. Detre K, et al. Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. Clin Transplant 1994, 8(3 Pt 1):274-280.
8. Acharya SK, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996, 23(6):1448-1455.
9. Masada CT, et al. Fulminant hepatic failure with massive necrosis as a result of hepatitis A infection. J Clin Gastroenterol 1993, 17(2):158-162.
10. Liaw YF, et al. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986, 14(4):156-158.
11. Mathiesen LR, et al. Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut 1980, 21(1):72-77.
12. Williams R, Wendon J Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 1994, 20(1 Pt 2):S5-S10.
13. Lee WM Acute liver failure. N Engl J Med 1993, 329(25):1862-1872.
14. Akriviadis EA, Redeker AG Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med 1989, 110(10):838-839.
15. Vento S, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998, 338(5):286-290.
16. Gane E, et al. Clinical recurrence of hepatitis A following liver transplantation for acute liver failure. J Med Virol 1995, 45(1):35-39.
17. Lettau LA, et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987, 317(20):1256-1262.
18. Bernuau J, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986, 6(4):648-651.
19. Wu JC, et al. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology 1994, 19(4):836-840.
20. Chu CM, Liaw YF The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection 1990, 18(4):200-203.
21. Brechot C, et al. Multiplication of hepatitis B virus in fulminant hepatitis B. Br Med J (Clin Res Ed) 1984, 288(6413):270-271.
22. Saracco G, et al. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med 1988, 108(3):380-383.
23. Wright TL, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992, 339(8799):952-955.
24. Lok AS, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991, 100(1):182-188.
25. Smedile A, et al. Influence of delta infection on severity of hepatitis B. Lancet 1982, 2(8305):945-947.
26. Govindarajan S, et al. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984, 86(6):1417-1420.
27. Wright TL, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991, 115(2):111-112.
28. Rolando N, et al. An open, comparative trial of aztreonam with vancomycin and gentamicin with piperacillin in patients with fulminant hepatic failure. J Antimicrob Chemother 1992, 30(2):215-220.
29. Yoshiba M, et al. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994, 19(4):829-835.
30. Feray C, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993, 104(2):549-555.
31. Nanda SK, et al. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994, 42(2):133-137.
32. Krawczynski K Hepatitis E. Hepatology 1993, 17(5):932-941.
33. Chase RA, et al. Herpes simplex viral hepatitis in adults: two case reports and review of the literature. Rev Infect Dis 1987, 9(2):329-333.
34. Ichai P, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl 2005, 11(12):1550-1555.
35. Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver 1999, Lippincott Williams & Wilkins, Philadelphia. 2nd ed. H.J. Zimmerman, H.J. Zimmerman (Eds.).
36. Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4(1):73-96.
37. Sze G, Kaplowitz N Drug hepatotoxicity as a cause of acute liver failure. Acute liver failure 1997, 19-31. Cambridge University Press, Cambridge, UK. 1st ed. W.M. Lee, R. Williams (Eds.).
38. Pessayre D, et al. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 1977, 72(2):284-289.
39. Chalasani N, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008, 135(6):1924-1934.
40. Andreu V, et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998, 29(3):394-397.
41. Bernal W, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007, 46(6):1844-1852.
42. Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42(6):1364-1372.
43. Zimmerman HJ, Maddrey WC Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995, 22(3):767-773.
44. O'Grady JG, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988, 94(5 Pt 1):1186-1192.
45. O'Grady J Clinical disorders of renal function in acute liver failure. Ascites and renal dysfunction in liver disease 2005, 383-393. Blackwell, Malden, Mass. 2nd ed. P. Gines (Ed.).
46. Stravitz RT, Kramer DJ Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009, 6(9):542-553.
47. Mitchell JR, et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973, 187(1):211-217.
48. Manyike PT, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000, 67(3):275-282.
49. Makin A, Williams R Acetaminophen-induced acute liver failure. Acute liver failure 1997, 32-42. Cambridge University Press, Cambridge, UK. 1st ed. W.M. Lee, R. Williams (Eds.).
50. Schiodt FV, et al. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997, 337(16):1112-1117.
51. Seeff LB, et al. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986, 104(3):399-404.
52. Rumack BH Acetaminophen misconceptions. Hepatology 2004, 40(1):10-15.
53. Broussard CN, et al. Mushroom poisoning: from diarrhea to liver transplantation. Am J Gastroenterol 2001, 96(11):3195-3198.
54. Mahler H, et al. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med 1997, 336(16):1142-1148.
55. Stedman C Herbal hepatotoxicity. Semin Liver Dis 2002, 22(2):195-206.
56. Korman JD, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008, 48(4):1167-1174.
57. Berman DH, et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991, 100(4):1129-1134.
58. Schiodt FV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999, 5(1):29-34.
59. Belay ED, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999, 340(18):1377-1382.
60. Treem WR Inherited and acquired syndromes of hyperammonemia and encephalopathy in children. Semin Liver Dis 1994, 14(3):236-258.
61. Squires RH Acute liver failure in children. Semin Liver Dis 2008, 28(2):153-166.
62. Squires RH, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006, 148(5):652-658.
63. Hamid SS, et al. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?. J Hepatol 1996, 25(1):20-27.
64. Castro MA, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999, 181(2):389-395.
65. Ibdah JA, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340(22):1723-1731.
66. Zarrinpar A, et al. Liver transplantation for HELLP syndrome. Am Surg 2007, 73(10):1013-1016.
67. Stravitz RT, et al. Autoimmune hepatitis presenting as acute liver failure: distinguishing clinical and histological features. Am J Transplant 2008, 8:195. (abstract).
68. Hofer H, et al. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006, 59(3):246-249.
69. Ichai P, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007, 13(7):996-1003.
70. Powell-Jackson PR, Ede RJ, Williams R Budd-Chiari syndrome presenting as fulminant hepatic failure. Gut 1986, 27(9):1101-1105.
71. Ichai P, et al. Fulminant hepatitis after grand mal seizures: mechanisms and role of liver transplantation. Hepatology 2003, 38(2):443-451.
72. Harrison HB, et al. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981, 80(4):820-825.
73. Oldhafer KJ, et al. Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation 1999, 67(7):1024-1028.
74. Klein AS, Cameron JL Diagnosis and management of the Budd-Chiari syndrome. Am J Surg 1990, 160(1):128-133.
75. Roche-Sicot J, Benhamou JP Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med 1977, 86(3):301-303.
76. Blei AT The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005, 47(1-2):71-77.
77. Losser MR, Payen D Mechanisms of liver damage. Semin Liver Dis 1996, 16(4):357-367.
78. Clemmesen JO, Kondrup J, Ott P Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000, 118(6):1131-1139.
79. Record CO, et al. Disturbances of lactate metabolism in patients with liver damage due to paracetamol overdose. Metabolism 1981, 30(7):638-643.
80. Record CO, et al. Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose. Clin Sci Mol Med 1975, 49(5):473-479.
81. Record CO, et al. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975, 16(2):144-149.
82. Pereira SP, Langley PG, Williams R The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996, 16(4):403-414.
83. Pernambuco JR, et al. Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology 1993, 18(6):1350-1356.
84. Pereira LM, et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992, 33(1):98-102.
85. Iwai H, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998, 26(5):873-876.
86. De La MM, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990, 82(3):479-484.
87. Wendon JA, et al. Arterial-venous pH differences and tissue hypoxia in patients with fulminant hepatic failure. Crit Care Med 1991, 19(11):1362-1364.
88. Schneider F, et al. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994, 19(1):38-44.
89. Trewby PN, et al. Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure. Gastroenterology 1978, 74(5 Pt 1):859-865.
90. Baudouin SV, et al. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995, 50(4):399-402.
91. Rolando N, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32(4 Pt 1):734-739.
92. Moore K Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 1999, 11(9):967-975.
93. Leithead JA, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 2009, 58(3):443-449.
94. Alam AN, et al. Intracellular electrolyte abnormalities in fulminant hepatic failure. Gastroenterology 1977, 72(5 Pt 1):914-917.
95. Schmidt LE, Dalhoff K Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002, 36(3):659-665.
96. Tripodi A, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005, 41(3):553-558.
97. Munoz SJ, Stravitz RT, Gabriel DA Coagulopathy of acute liver failure. Clin Liver Dis 2009, 13(1):95-107.
98. Valla D, et al. Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology 1989, 10(4):482-487.
99. Weston MJ, et al. Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure. Gut 1974, 15(6):482-486.
100. Schiodt FV, et al. Thrombopoietin in acute liver failure. Hepatology 2003, 37(3):558-561.
101. Williams AM, et al. Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver Int 2003, 23(2):110-115.
102. Yamaguchi M, et al. Decreased protein C activation in patients with fulminant hepatic failure. Scand J Gastroenterol 2006, 41(3):331-337.
103. Rolando N, Philpott-Howard J, Williams R Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996, 16(4):389-402.
104. Rolando N, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990, 11(1):49-53.
105. Ede RJ, et al. Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers. Gut 1988, 29(6):778-781.
106. Gazzard BG, et al. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975, 44(176):615-626.
107. Vaquero J, et al. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003, 23(3):259-269.
108. Larsen FS, Wendon J Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 2008, 14(Suppl 2):S90-S96.
109. Larsen FS, et al. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 1995, 23(2):212-217.
110. Clemmesen JO, et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999, 29(3):648-653.
111. Butterworth RF Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role?. Hepatology 1997, 25(4):1032-1034.
112. Cordoba J, Gottstein J, Blei AT Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996, 24(4):919-923.
113. McConnell JR, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995, 22(1):69-74.
114. Ruprah M, Mant TG, Flanagan RJ Acute carbon tetrachloride poisoning in 19 patients: implications for diagnosis and treatment. Lancet 1985, 1(8436):1027-1029.
115. Smilkstein MJ, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988, 319(24):1557-1562.
116. Mitchell JR, et al. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther 1974, 16(4):676-684.
117. Harrison PM, et al. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991, 324(26):1852-1857.
118. Rumack BH, Matthew H Acetaminophen poisoning and toxicity. Pediatrics 1975, 55(6):871-876.
119. Davern TJ, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006, 130(3):687-694.
120. Keays R, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991, 303(6809):1026-1029.
121. Makin AJ, Wendon J, Williams R A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995, 109(6):1907-1916.
122. Makin AJ, Williams R Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 1997, 42:453-483.
123. Smilkstein MJ, et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991, 20(10):1058-1063.
124. Perry HE, Shannon MW Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998, 132(1):149-152.
125. Stravitz RT, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group. Crit Care Med 2007, 35(11):2498-2508.
126. Lee WM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009, 137(3):856-864.
127. Floersheim GL, et al. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol 1978, 46(2):455-462.
128. Koppel C Clinical symptomatology and management of mushroom poisoning. Toxicon 1993, 31(12):1513-1540.
129. Kumar M, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007, 45(1):97-101.
130. Knochel JP Does hypophosphatemia play a role in acute liver failure?. Hepatology 1989, 9(3):504-505.
131. Oswiecimski P, et al. Profound hypocalcemia in fulminant hepatic failure. Am J Gastroenterol 2000, 95(3):824-825.
132. O'Keefe SJ, et al. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 1980, 2(8195 Pt 1):615-617.
133. Chase RA, et al. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology 1978, 75(6):1033-1040.
134. Munoz SJ Nutritional therapies in liver disease. Semin Liver Dis 1991, 11(4):278-291.
135. Harrison PM, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990, 301(6758):964-966.
136. Munoz SJ, et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant Proc 1989, 21(3):3535-3536.
137. Shami VM, et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003, 9(2):138-143.
138. MacGilchrist AJ, Sumner D, Reid JL Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991, 13(4):689-694.
139. Clemmesen JO, et al. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. Scand J Gastroenterol 1999, 34(9):921-927.
140. Shawcross DL, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004, 39(2):471-475.
141. Harry R, Auzinger G, Wendon J The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 2002, 36(2):395-402.
142. Strauss G, Larsen FS Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998, 28(2):199-203.
143. Aggarwal S, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 1994, 19(1):80-87.
144. Wade JJ, et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21(5):1328-1336.
145. Rolando N, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991, 12(1):1-9.
146. Rolando N, et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993, 17(2):196-201.
147. Salmeron JM, et al. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. J Hepatol 1992, 14(2-3):280-285.
148. Rolando N, et al. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol 2000, 12(10):1135-1140.
149. Davenport A, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 1989, 12(7):439-444.
150. Blei AT Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991, 13(2):376-379.
151. Vaquero J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003, 125(3):755-764.
152. Hanid MA, et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980, 21(10):866-869.
153. Canalese J, et al. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982, 23(7):625-629.
154. Bernal W, et al. Intensive care management of acute liver failure. Semin Liver Dis 2008, 28(2):188-200.
155. Murphy N, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39(2):464-470.
156. Keays R, et al. Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med 1991, 79(289):425-433.
157. Wijdicks EF, Nyberg SL Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002, 34(4):1220-1222.
158. Lidofsky SD, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992, 16(1):1-7.
159. Forbes A, et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989, 10(3):306-310.
160. Tofteng F, Larsen FS The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004, 24(7):798-804.
161. Stravitz RT, Larsen F Therapeutic hypothermia for acute liver failure. Crit Care Med 2009, 37:S258-S264.
162. Ellis AJ, Wendon JA, Williams R Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000, 32(3):536-541.
163. Bhatia V, Batra Y, Acharya SK Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure: a controlled clinical trial. J Hepatol 2004, 41(1):89-96.
164. Larsen FS, et al. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. Transplant Proc 1994, 26(3):1788.
165. Liou IW, Larson AM Role of liver transplantation in acute liver failure. Semin Liver Dis 2008, 28(2):201-209.
166. Lee WM Etiologies of acute liver failure. Semin Liver Dis 2008, 28(2):142-152.
167. Ostapowicz G, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137(12):947-954.
168. Farmer DG, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003, 237(5):666-675.
169. Ascher NL, et al. Liver transplantation for fulminant hepatic failure. Arch Surg 1993, 128(6):677-682.
170. Bismuth H, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995, 222(2):109-119.
171. Bismuth H, et al. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996, 16(4):415-425.
172. Devlin J, et al. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology 1995, 21(4):1018-1024.
173. Campsen J, et al. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008, 14:1273-1280.
174. van Hoek B, et al. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT study group. European Auxiliary Liver Transplant Registry. J Hepatol 1999, 30(4):699-705.
175. Lake JR, Sussman NL Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer. Hepatology 1995, 21(3):879-882.
176. Karvountzis GG, Redeker AG, Peters RL Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 1974, 67(5):870-877.
177. Anand AC, Nightingale P, Neuberger JM Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997, 26(1):62-68.
178. Pauwels A, et al. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 1993, 17(1):124-127.
179. Shakil AO, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6(2):163-169.
180. Mitchell I, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998, 26(2):279-284.
181. Bernuau J, Samuel D, Durand F Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology 1991, 14:49A. (abstract).
182. Izumi S, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996, 23(6):1507-1511.
183. Bernal W, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359(9306):558-563.
184. Scotto J, et al. Liver biopsy and prognosis in acute liver failure. Gut 1973, 14(12):927-933.
185. Donaldson BW, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993, 18(6):1370-1376.
186. Horney JT, Galambos JT The liver during and after fulminant hepatitis. Gastroenterology 1977, 73(4 Pt 1):639-645.
187. Hanau C, Munoz SJ, Rubin R Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995, 21(2):345-351.
188. Schiodt FV, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006, 12(12):1776-1781.
189. Acharya SK, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996, 23(6):1448-1455. (Ref.8).
190. Anand AC, Nightingale P, Neuberger JM Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997, 26(1):62-68. (Ref.177).
191. Andreu V, et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998, 29(3):394-397. (Ref.40).
192. Baudouin SV, et al. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995, 50(4):399-402. (Ref.90).
193. Belay ED, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999, 340(18):1377-1382. (Ref.59).
194. Bernal W, et al. Intensive care management of acute liver failure. Semin Liver Dis 2008, 28(2):188-200. (Ref.154).
195. Bernal W, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359(9306):558-563. (Ref.183).
196. Bernal W, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007, 46(6):1844-1852. (Ref.41).
197. Bhatia V, Batra Y, Acharya SK Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure: a controlled clinical trial. J Hepatol 2004, 41(1):89-96. (Ref.163).
198. Bismuth H, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995, 222(2):109-119. (Ref.170).
199. Bismuth H, et al. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996, 16(4):415-425. (Ref.171).
200. Blei AT The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005, 47(1-2):71-77. (Ref.76).
201. Broussard CN, et al. Mushroom poisoning: from diarrhea to liver transplantation. Am J Gastroenterol 2001, 96(11):3195-3198. (Ref.53).
202. Butterworth RF Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role?. Hepatology 1997, 25(4):1032-1034. (Ref.111).
203. Campsen J, et al. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008, 14:1273-1280. (Ref.173).
204. Castro MA, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999, 181(2):389-395. (Ref.64).
205. Chalasani N, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008, 135(6):1924-1934. (Ref.39).
206. Clemmesen JO, et al. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. Scand J Gastroenterol 1999, 34(9):921-927. (Ref.139).
207. Clemmesen JO, Kondrup J, Ott P Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000, 118(6):1131-1139. (Ref.78).
208. Clemmesen JO, et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999, 29(3):648-653. (Ref.110).
209. Cordoba J, Gottstein J, Blei AT Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996, 24(4):919-923. (Ref.112).
210. Davern TJ, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006, 130(3):687-694. (Ref.119).
211. Devlin J, et al. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology 1995, 21(4):1018-1024. (Ref.172).
212. Ellis AJ, et al. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 1995, 23(4):363-372. (Ref.5).
213. Ellis AJ, Wendon JA, Williams R Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000, 32(3):536-541. (Ref.162).
214. Farmer DG, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003, 237(5):666-675. (Ref.168).
215. Gane E, et al. Clinical recurrence of hepatitis A following liver transplantation for acute liver failure. J Med Virol 1995, 45(1):35-39. (Ref.16).
216. Hamid SS, et al. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?. J Hepatol 1996, 25(1):20-27. (Ref.63).
217. Hanau C, Munoz SJ, Rubin R Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995, 21(2):345-351. (Ref.187).
218. Harry R, Auzinger G, Wendon J The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 2002, 36(2):395-402. (Ref.141).
219. Hofer H, et al. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006, 59(3):246-249. (Ref.68).
220. Ibdah JA, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340(22):1723-1731. (Ref.65).
221. Ichai P, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl 2005, 11(12):1550-1555. (Ref.34).
222. Ichai P, et al. Usefulness of corticosteroids for the treatment of
223. Ichai P, et al. Fulminant hepatitis after grand mal seizures: mechanisms and role of liver transplantation. Hepatology 2003, 38(2):443-451. (Ref.71).
224. Iwai H, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998, 26(5):873-876. (Ref.85).
225. Izumi S, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996, 23(6):1507-1511. (Ref.182).
226. Korman JD, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008, 48(4):1167-1174. (Ref.56).
227. Kumar M, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007, 45(1):97-101. (Ref.129).
228. Lake JR, Sussman NL Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer. Hepatology 1995, 21(3):879-882. (Ref.175).
229. Larsen FS, et al. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 1995, 23(2):212-217. (Ref.109).
230. Larsen FS, Wendon J Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 2008, 14(Suppl 2):S90-S96. (Ref.108).
231. Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42(6):1364-1372. (Ref.42).
232. Lee WM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009, 137(3):856-864. (Ref.126).
233. Lee WM Acute liver failure in the United States. Semin Liver Dis 2003, 23(3):217-226. (Ref.6).
234. Lee WM Etiologies of acute liver failure. Semin Liver Dis 2008, 28(2):142-152. (Ref.166).
235. Leithead JA, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 2009, 58(3):443-449. (Ref.93).
236. Liou IW, Larson AM Role of liver transplantation in acute liver failure. Semin Liver Dis 2008, 28(2):201-209. (Ref.165).
237. Losser MR, Payen D Mechanisms of liver damage. Semin Liver Dis 1996, 16(4):357-367. (Ref.77).
238. Mahler H, et al. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med 1997, 336(16):1142-1148. (Ref.54).
239. Makin A, Williams R Acetaminophen-induced acute liver failure. Acute liver failure 1997, 32-42. Cambridge University Press, Cambridge, UK, (Ref.49). 1st ed. W.M. Lee, R. Williams (Eds.).
240. Makin AJ, Wendon J, Williams R A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995, 109(6):1907-1916. (Ref.121).
241. Makin AJ, Williams R Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 1997, 42:453-483. (Ref.122).
242. Manyike PT, et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000, 67(3):275-282. (Ref.48).
243. McConnell JR, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995, 22(1):69-74. (Ref.113).
244. Mitchell I, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998, 26(2):279-284. (Ref.180).
245. Moore K Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 1999, 11(9):967-975. (Ref.92).
246. Munoz SJ, Stravitz RT, Gabriel DA Coagulopathy of acute liver failure. Clin Liver Dis 2009, 13(1):95-107. (Ref.97).
247. Murphy N, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39(2):464-470. (Ref.155).
248. O'Grady J Clinical disorders of renal function in acute liver failure. Ascites and renal dysfunction in liver disease 2005, 383-393. Blackwell, Malden, Mass, (Ref.45). 2nd ed. P. Gines, V. Arroyo, J. Rodes, R. Schrier (Eds.).
249. Oldhafer KJ, et al. Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation 1999, 67(7):1024-1028. (Ref.73).
250. Ostapowicz G, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137(12):947-954. (Ref.167).
251. Oswiecimski P, et al. Profound hypocalcemia in fulminant hepatic failure. Am J Gastroenterol 2000, 95(3):824-825. (Ref.131).
252. Pereira SP, Langley PG, Williams R The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996, 16(4):403-414. (Ref.82).
253. Perry HE, Shannon MW Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998, 132(1):149-152. (Ref.124).
254. Rolando N, et al. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol 2000, 12(10):1135-1140. (Ref.148).
255. Rolando N, Philpott-Howard J, Williams R Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996, 16(4):389-402. (Ref.103).
256. Rolando N, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32(4 Pt 1):734-739. (Ref.91).
257. Rumack BH Acetaminophen misconceptions. Hepatology 2004, 40(1):10-15. (Ref.52).
258. Schiodt FV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999, 5(1):29-34. (Ref.58).
259. Schiodt FV, et al. Thrombopoietin in acute liver failure. Hepatology 2003, 37(3):558-561. (Ref.100).
260. Schiodt FV, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006, 12(12):1776-1781. (Ref.188).
261. Schiodt FV, et al. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997, 337(16):1112-1117. (Ref.50).
262. Schmidt LE, Dalhoff K Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002, 36(3):659-665. (Ref.95).
263. Shakil AO, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6(2):163-169. (Ref.179).
264. Shami VM, et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003, 9(2):138-143. (Ref.137).
265. Shawcross DL, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004, 39(2):471-475. (Ref.140).
266. Squires RH Acute liver failure in children. Semin Liver Dis 2008, 28(2):153-166. (Ref.61).
267. Squires RH, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006, 148(5):652-658. (Ref.62).
268. Stedman C Herbal hepatotoxicity. Semin Liver Dis 2002, 22(2):195-206. (Ref.55).
269. Strauss G, et al. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998, 28(2):199-203. (Ref.142).
270. Stravitz RT, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group. Crit Care Med 2007, 35(11):2498-2508. (Ref.125).
271. Stravitz RT, Kramer DJ Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009, 6(9):542-553. (Ref.46).
272. Stravitz RT, Larsen F Therapeutic hypothermia for acute liver failure. Crit Care Med 2009, 37:S258-S264. (Ref.161).
273. Stravitz RT, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2010, Nov. 18 (Epub ahead of print). (Ref.67).
274. Sze G, Kaplowitz N Drug hepatotoxicity as a cause of acute liver failure. Acute liver failure 1997, 19-31. Cambridge University Press, Cambridge, UK, (Ref.37). 1st ed. W.M. Lee, R. Williams (Eds.).
275. Tofteng F, Larsen FS The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004, 24(7):798-804. (Ref.160).
276. Tripodi A, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005, 41(3):553-558. (Ref.96).
277. van Hoek B, et al. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT study group. European Auxiliary Liver Transplant Registry. J Hepatol 1999, 30(4):699-705. (Ref.174).
278. Vaquero J, et al. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003, 23(3):259-269. (Ref.107).
279. Vaquero J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003, 125(3):755-764. (Ref.151).
280. Vento S, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998, 338(5):286-290. (Ref.15).
281. Wade JJ, et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21(5):1328-1336. (Ref.144).
282. Wijdicks EF, Nyberg SL Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002, 34(4):1220-1222. (Ref.157).
283. Williams AM, et al. Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver Int 2003, 23(2):110-115. (Ref.101).
284. Yamaguchi M, et al. Decreased protein C activation in patients with fulminant hepatic failure. Scand J Gastroenterol 2006, 41(3):331-337. (Ref.102).
285. Zarrinpar A, et al. Liver transplantation for HELLP syndrome. Am Surg 2007, 73(10):1013-1016. (Ref.66).
286. Zimmerman HJ, Maddrey WC Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995, 22(3):767-773. (Ref.43).
287. Zimmerman HJ Drug-induced liver disease. Clin Liver Dis 2000, 4(1):73-96. (Ref.36).
288. Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver 1999, Lippincott Williams & Wilkins, Philadelphia, (Ref.35). 2nd ed. H.J. Zimmerman, H.J. Zimmerman (Eds.).